Vyne Therapeutics
Price & Volume
Stats
See more52W Range | $0.28-$3.40 |
Market Cap | $18.9M |
Shares Short | 482,674 |
Financials
See moreRevenue (12 Mos) | $524,000 |
Revenue Growth (YoY) | 39.7% |
Gross Profit (12 Mos) | $524,000 |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 25 days ago
BC-Most Active Stocks
Yahoo Finance • 2 months ago
VYNE Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $0.2M beats by $0.1M
Yahoo Finance • 5 months ago
Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Yahoo Finance • 5 months ago
The trading volume of these stocks is deviating from the norm in today's session.
About
CEO | Mr. David T. Domzalski |
CFO | Mr. Tyler Zeronda CPA |
Address | 685 Route 202/206 N, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
